Profound Medical
PROF
44 hedge funds and large institutions have $73.7M invested in Profound Medical in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 9 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
0% more capital invested
Capital invested by funds: $73.6M → $73.7M (+$4.59K)
1.19% less ownership
Funds ownership: 42.73% → 41.53% (-1.2%)
10% less funds holding
Funds holding: 49 → 44 (-5)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
93% less call options, than puts
Call options by funds: $3K | Put options by funds: $40K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$645K |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$370K |
| 3 |
GS
Gagnon Securities
New York
|
+$276K |
| 4 |
RMC
Ring Mountain Capital
Tiburon,
California
|
+$272K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$259K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$814K |
| 2 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$795K |
| 3 |
CIC
Chilton Investment Company
Stamford,
Connecticut
|
-$378K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$145K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$138K |
PROF Hedge Fund Activity: Q2 2025 in Review
44 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q2 2025, worth a combined $73.7M — up 0.01% from $73.6M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PROF and 4 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 16 added.
The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $645K. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $814K sold.
- 44 institutional investors held Profound Medical (PROF) as of Q2 2025, down from 49 in Q1 2025.
- Funds reported $73.7M of Profound Medical stock for Q2 2025, up 0.01% quarter-over-quarter.
- 4 funds opened new Profound Medical positions in Q2 2025 and 9 closed out, a net change of -5 holders.
- The largest Profound Medical buyer in Q2 2025 was First Eagle Investment Management, an estimated $645K added.
- The largest Profound Medical seller in Q2 2025 was Stonepine Capital Management, an estimated $814K sold.
Based on aggregated 13F filings for Q2 2025.